Literature DB >> 28848850

Validation of the St. George's Respiratory Questionnaire in Nepal.

Chundak T Sherpa1, Steven L LeClerq2, Shakuntala Singh3, Neha Naithani2, Raju Pangeni3, Arjun Karki4, Ramesh K Chokhani5, MeiLan Han6, Margaret Gyetko6, James M Tielsch7, William Checkley1,2.   

Abstract

The St. George's Respiratory Questionnaire (SGRQ) is a standardized questionnaire for measuring impaired health and perceived well-being in chronic airway disease, but it is not available in the Nepali language. We translated the original SGRQ into Nepali and validated its use in 150 individuals aged 40 to 80 years with and without COPD.We also examined if the SGRQ could be used as a screening tool to identify individuals at risk for COPD. We translated the SGRQ following a standard protocol. The validation study was then conducted in both community and hospital-based settings in Nepal. We enrolled 100 participants from a community setting who were not actively seeking medical care, 50 of which met criteria for chronic obstructive pulmonary disease (COPD) (post-bronchodilator forced expiratory volume in 1 second [FEV1]/ forced vital capacity [FVC]<70%) and 50 who did not. We also enrolled 50 participants with an established diagnosis of COPD who attended outpatient pulmonary clinics. All participants completed the questionnaire. We used linear regressions to compare average SGRQ scores by disease status categories and by lung function values, adjusted for age, sex, height and body mass index (BMI).All 150 participants (mean age 59.8 years, 48% male, mean BMI 20.5 kg/m2) completed the SGRQ. In multivariable regression, the average SGRQ total score was 23.9 points higher in established cases of COPD and 18.1 points higher in community cases of COPD when compared to participants without COPD living in the community (all p<0.001). The SGRQ total score also increased by an average of 2.1 points for each 100 mL decrease in post-FEV1 (p<0.001). The area-under-the-curve for the SGRQ total score as a predictor of COPD was 0.77 (95% confidence interval [CI] 0.68 to 0.85) and the optimal cutoff to identify COPD was 33 points.We developed a Nepali-validated version of SGRQ, which correlated well with both disease status and severity.

Entities:  

Keywords:  biomass fuels; chronic obstructive pulmonary disease; copd; population studies; quality of life assessment; questionnaire validation; risk factors

Year:  2015        PMID: 28848850      PMCID: PMC5556824          DOI: 10.15326/jcopdf.2.4.2014.0156

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  22 in total

Review 1.  Global burden of COPD: risk factors, prevalence, and future trends.

Authors:  David M Mannino; A Sonia Buist
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

2.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1992-06

3.  Supplementation with vitamin A early in life and subsequent risk of asthma.

Authors:  W Checkley; K P West; R A Wise; L Wu; S C LeClerq; S Khatry; J Katz; P Christian; J M Tielsch; A Sommer
Journal:  Eur Respir J       Date:  2011-06-23       Impact factor: 16.671

4.  American translation, modification, and validation of the St. George's Respiratory Questionnaire.

Authors:  J T Barr; G E Schumacher; S Freeman; M LeMoine; A W Bakst; P W Jones
Journal:  Clin Ther       Date:  2000-09       Impact factor: 3.393

5.  Maternal vitamin A supplementation and lung function in offspring.

Authors:  William Checkley; Keith P West; Robert A Wise; Matthew R Baldwin; Lee Wu; Steven C LeClerq; Parul Christian; Joanne Katz; James M Tielsch; Subarna Khatry; Alfred Sommer
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

6.  Validation of the St. George's Respiratory Questionnaire in patients with COPD or asthma in Morocco.

Authors:  K El Rhazi; C Nejjari; M C Benjelloun; J Bourkadi; H Afif; Z Serhier; N Tachfouti; M Berraho; P Barberger-Gateau
Journal:  Int J Tuberc Lung Dis       Date:  2006-11       Impact factor: 2.373

7.  Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.

Authors:  M Miravitlles; M Ferrer; A Pont; R Zalacain; J L Alvarez-Sala; F Masa; H Verea; C Murio; F Ros; R Vidal
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

8.  Ventilated cookstoves associated with improvements in respiratory health-related quality of life in rural Bolivia.

Authors:  Donee Alexander; Jacqueline Callihan Linnes; Susan Bolton; Timothy Larson
Journal:  J Public Health (Oxf)       Date:  2013-08-21       Impact factor: 2.341

9.  Development and first validation of the COPD Assessment Test.

Authors:  P W Jones; G Harding; P Berry; I Wiklund; W-H Chen; N Kline Leidy
Journal:  Eur Respir J       Date:  2009-09       Impact factor: 16.671

Review 10.  Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review.

Authors:  Marie Westwood; Jean Bourbeau; Paul W Jones; Annamaria Cerulli; Gorana Capkun-Niggli; Gill Worthy
Journal:  Respir Res       Date:  2011-04-08
View more
  7 in total

1.  The Effect of Treatment during A Haze/Post-Haze Year on Subsequent Respiratory Morbidity Status among Successful Treatment Tuberculosis Cases.

Authors:  Suyanto Suyanto; Alan Geater; Virasakdi Chongsuvivatwong
Journal:  Int J Environ Res Public Health       Date:  2019-11-23       Impact factor: 3.390

2.  Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial.

Authors:  Trishul Siddharthan; Suzanne L Pollard; Peter Jackson; Nicole M Robertson; Adaeze C Wosu; Nihaal Rahman; Roma Padalkar; Isaac Sekitoleko; Esther Namazzi; Patricia Alupo; John R Hurst; Robert Kalyesubula; David Dowdy; Robert Wise; Peter J Barnes; William Checkley; Bruce Kirenga
Journal:  Trials       Date:  2021-03-16       Impact factor: 2.279

3.  Evaluation of a chest rehabilitation project in Nepal using the St. George's Respiratory Questionnaire and Chronic Obstructive Pulmonary Disease Assessment Test.

Authors:  Atsushi Sato; Mitsuhiro Kamimura; Keisuke Yorimoto; Taro Kato; Shohei Yamashita; Atsuto Mouri; Motoaki Tanigawa; Yoshihito Arimoto; Junko Fujitani; Karbir Nath Yogi; Khem Bahadur Karki; Shigeki Hayashi
Journal:  J Phys Ther Sci       Date:  2020-12-11

4.  Community-based intervention for prevention and management of chronic obstructive pulmonary disease in Nepal (COBIN-P trial): study protocol for a cluster-randomized controlled trial.

Authors:  Tara Ballav Adhikari; Dinesh Neupane; Arjun Karki; Arne Drews; Brendan Cooper; Marieann Högman; Torben Sigsgaard; Per Kallestrup
Journal:  Trials       Date:  2021-07-21       Impact factor: 2.279

5.  Psychometric properties of Patient Reported Outcome Measures (PROMs) in patients diagnosed with Acute Respiratory Distress Syndrome (ARDS).

Authors:  Hiral Anil Shah; Melina Dritsaki; Joshua Pink; Stavros Petrou
Journal:  Health Qual Life Outcomes       Date:  2016-01-27       Impact factor: 3.186

6.  Validation of the Saint George's Respiratory Questionnaire in Uganda.

Authors:  Brooks W Morgan; Matthew R Grigsby; Trishul Siddharthan; Robert Kalyesubula; Robert A Wise; John R Hurst; Bruce Kirenga; William Checkley
Journal:  BMJ Open Respir Res       Date:  2018-07-11

7.  Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol.

Authors:  Trishul Siddharthan; Suzanne L Pollard; Shumonta A Quaderi; Andrew J Mirelman; Maria Kathia Cárdenas; Bruce Kirenga; Natalie A Rykiel; J Jaime Miranda; Laxman Shrestha; Ram K Chandyo; Adithya Cattamanchi; Susan Michie; Julie Barber; William Checkley; John R Hurst
Journal:  Trials       Date:  2018-10-19       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.